Monday, March 23, 2026

Light/Dark

Breaking News

Cathay Pacific Expands Global Partnership with Adyen MAS Partners Industry to Develop AI Risk Management Toolkit for the Financial Sector Novidea Releases Updated Version of Its Insurance Management Platform with Significant Enhancements Across Policy Administration, Bordereaux, Claims and Accounting CV5 Capital and Formatnull Investment Management Prepares Launch Cayman-Domiciled Digital Asset Hedge Fund Pro Global Scales Latin American Hub as Hybrid Model Accelerates Latin America Growth Dext Launches AI Assist to Automate Everyday Bookkeeping Decisions Equifax Launches Free App to Help Consumers Find Old or Missing Paperwork in Time for the FCA’s Redress Scheme Chubb Details Structure of the Gulf Maritime Insurance Facility with DFC Zempler Bank Appoints Dominic Wade as New CEO Stablecoin Settlement Models Face Compliance and Partner Hurdles, Finds Clear Junction Montrose First in Europe to Let Customers Connect Their Portfolio to Their Own AI Interface Finance Leaders Cautious About AI Despite Recognising Productivity Benefits, New Research Reveals Finclusion Introduces Upfront Affordability Assessments as Motor Finance Sector Faces Increased Scrutiny Moniepoint Acquires Orda Africa to Power Africa’s Restaurant Economy Paysafe and BIG Form New Esports Partnership with PaysafeCard as Official Payments Sponsor

Home » People » Tan Truong

Lamin Jaiteh

Connect

About Tan Truong

https://in-prepaid.com/

News

News

Dash Solutions expands its payments platform into healthcare and clinical trials, with COO Tan Truong and CEO Stephen Faust highlighting 20% growth in 2025.

Dash Solutions Expands Reach of Unified Payments Platform in Regulated Industries

September 11 2025

Dash Solutions, the leader in payments enablement, today announced the expanded reach of its unified, enterprise-grade platform, which currently powers complex payment workflows for banking, government and other regulated industries. Building on this foundation, Dash Solutions is rapidly scaling in healthcare and clinical research, with the company on pace to grow its clinical trials business by 20% this year alone.

Related Companies